Found: 146
Select item for more details and to access through your institution.
Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 20, p. 1763, doi. 10.1001/jama.2024.5296
- By:
- Publication type:
- Article
Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib.
- Published in:
- American Journal of Managed Care, 2024, v. 30, n. 4, p. 193, doi. 10.37765/ajmc.2024.89531
- By:
- Publication type:
- Article
Hospital and Physician Group Practice Participation in Prior and Next-Generation Value-Based Payment Programs.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e240392, doi. 10.1001/jamanetworkopen.2024.0392
- By:
- Publication type:
- Article
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data.
- Published in:
- Medical Care Research & Review, 2024, v. 81, n. 1, p. 78, doi. 10.1177/10775587231193475
- By:
- Publication type:
- Article
Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 1, p. 72, doi. 10.1001/jama.2023.23126
- By:
- Publication type:
- Article
Facility Fees for Colonoscopy Procedures at Hospitals and Ambulatory Surgery Centers.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 12, p. e234025, doi. 10.1001/jamahealthforum.2023.4025
- By:
- Publication type:
- Article
Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 16, p. 3640, doi. 10.1007/s11606-020-06198-y
- By:
- Publication type:
- Article
Correction to: Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 16, p. 3660, doi. 10.1007/s11606-021-07201-w
- By:
- Publication type:
- Article
Hospital Prices in Medicaid Managed Care.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2344841, doi. 10.1001/jamanetworkopen.2023.44841
- By:
- Publication type:
- Article
Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 10, p. e233660, doi. 10.1001/jamahealthforum.2023.3660
- By:
- Publication type:
- Article
Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 14, p. 1331, doi. 10.1001/jama.2023.17131
- By:
- Publication type:
- Article
Estimating Changes in Medicare Part D and Commercial Insurer Insulin Spending Amid Planned State-Led Biosimilar Insulin Production in California.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 7, p. 734, doi. 10.1001/jamainternmed.2023.0373
- By:
- Publication type:
- Article
Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 6, p. e231317, doi. 10.1001/jamahealthforum.2023.1317
- By:
- Publication type:
- Article
U.S. Hospitals' Administrative Expenses Increased Sharply During COVID-19.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 8, p. 1887, doi. 10.1007/s11606-023-08158-8
- By:
- Publication type:
- Article
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 5, p. e231090, doi. 10.1001/jamahealthforum.2023.1090
- By:
- Publication type:
- Article
Patterns of Manufacturer Coupon Use for Prescription Drugs in the US, 2017-2019.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2313578, doi. 10.1001/jamanetworkopen.2023.13578
- By:
- Publication type:
- Article
Commercial COVID-19 PCR Test Price in US Hospitals.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 5, p. 1341, doi. 10.1007/s11606-022-08013-2
- By:
- Publication type:
- Article
Accelerated approval drug labels often lack information for clinical decision‐making.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 4, p. 300, doi. 10.1002/phar.2789
- By:
- Publication type:
- Article
Why Are Some Value-Based Programs Successful?
- Published in:
- 2023
- By:
- Publication type:
- Opinion
When States Mandate Hospital Community Benefit Reports, Provision Increases.
- Published in:
- Journal of Healthcare Management, 2023, v. 68, n. 2, p. 83, doi. 10.1097/JHM-D-22-00156
- By:
- Publication type:
- Article
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 5, p. 386, doi. 10.1001/jama.2022.23968
- By:
- Publication type:
- Article
Association between non‐profit hospital community benefit spending and health outcomes.
- Published in:
- Health Services Research, 2023, v. 58, n. 1, p. 107, doi. 10.1111/1475-6773.14060
- By:
- Publication type:
- Article
Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2239868, doi. 10.1001/jamanetworkopen.2022.39868
- By:
- Publication type:
- Article
Anticipating Reforms to the Prescription Drug User Fees Act.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Site‐based payment differentials for ambulatory services among individuals with commercial insurance.
- Published in:
- Health Services Research, 2022, v. 57, n. 5, p. 1165, doi. 10.1111/1475-6773.13935
- By:
- Publication type:
- Article
Including Pharmaceuticals in Bundled Payments.
- Published in:
- Applied Health Economics & Health Policy, 2022, v. 20, n. 5, p. 625, doi. 10.1007/s40258-022-00742-z
- By:
- Publication type:
- Article
Association Between Open Payments-Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?
- Published in:
- Health Economics Review, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13561-022-00384-w
- By:
- Publication type:
- Article
Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?
- Published in:
- Health Economics Review, 2022, v. 12, p. 1, doi. 10.1186/s13561-022-00384-w
- By:
- Publication type:
- Article
Medicare Spending on Drugs With Accelerated Approval.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cover.
- Published in:
- Journal of the American Geriatrics Society, 2022, v. 70, n. 6, p. C1, doi. 10.1111/jgs.16594
- By:
- Publication type:
- Article
Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey.
- Published in:
- Journal of the American Geriatrics Society, 2022, v. 70, n. 6, p. 1685, doi. 10.1111/jgs.17692
- By:
- Publication type:
- Article
Reply to: The informed majority could help make research into Alzheimer's disease fairer and more efficient.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Comparison of Trends in Nonprofit Hospitals' Charity Care Eligibility Policies Between Medicaid Expansion States and Medicaid Nonexpansion States.
- Published in:
- Medical Care Research & Review, 2022, v. 79, n. 3, p. 458, doi. 10.1177/10775587211039695
- By:
- Publication type:
- Article
COVID-19 and Hospital Financial Viability in the US.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 5, p. e221018, doi. 10.1001/jamahealthforum.2022.1018
- By:
- Publication type:
- Article
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 5, p. e220888, doi. 10.1001/jamahealthforum.2022.0888
- By:
- Publication type:
- Article
Hospital resource allocation decisions when market prices exceed Medicare prices.
- Published in:
- Health Services Research, 2022, v. 57, n. 2, p. 237, doi. 10.1111/1475-6773.13914
- By:
- Publication type:
- Article
Comparing the value of community benefit and Tax‐Exemption in non‐profit hospitals.
- Published in:
- Health Services Research, 2022, v. 57, n. 2, p. 270, doi. 10.1111/1475-6773.13668
- By:
- Publication type:
- Article
Labor Market Concentration and Worker Contributions to Health Insurance Premiums.
- Published in:
- Medical Care Research & Review, 2022, v. 79, n. 2, p. 198, doi. 10.1177/10775587211012992
- By:
- Publication type:
- Article
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care Program.
- Published in:
- Milbank Quarterly, 2022, v. 100, n. 1, p. 190, doi. 10.1111/1468-0009.12546
- By:
- Publication type:
- Article
Measuring and Mitigating Gender-Based Disparities in Earning Potential in Academic Medicine.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Effects of an Out-of-Pocket Maximum in Medicare Part D.
- Published in:
- American Journal of Managed Care, 2022, v. 28, n. 2, p. e55, doi. 10.37765/ajmc.2022.88828
- By:
- Publication type:
- Article
INNOVATION IN THE UNITED STATES HEALTH-CARE SYSTEM'S ORGANIZATION AND DELIVERY.
- Published in:
- School of Public Policy Publications, 2022, v. 15, n. 2, p. 1
- By:
- Publication type:
- Article
The Association Between Drug Approvals and Burden of Disease From 1990 to 2017.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Association Between Waste-Free Formularies and Prescription Drug Spending Among Self-insured Employers.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2131486, doi. 10.1001/jamanetworkopen.2021.31486
- By:
- Publication type:
- Article
Factors Associated With Manufacturer Drug Coupon Use at US Pharmacies.
- Published in:
- JAMA Health Forum, 2021, v. 2, n. 8, p. 1, doi. 10.1001/jamahealthforum.2021.2123
- By:
- Publication type:
- Article
Hospital Inpatient Charges of COVID-19 Diagnostic Tests Ranged from $10 to $1390.
- Published in:
- Population Health Management, 2021, v. 24, n. 4, p. 433, doi. 10.1089/pop.2020.0283
- By:
- Publication type:
- Article
Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices.
- Published in:
- American Journal of Managed Care, 2021, v. 27, n. 7, p. 290, doi. 10.37765/ajmc.2021.88702
- By:
- Publication type:
- Article
Charity Care and Community Benefit in Non-Profit Hospitals: Definition and Requirements.
- Published in:
- Inquiry (00469580), 2021, v. 58, p. 1, doi. 10.1177/00469580211028180
- By:
- Publication type:
- Article
Characteristics of Copayment Offsets for Prescription Drugs in the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article